A new study has unveiled the genetic mechanism controlling citric acid content in jujube fruit, identifying a natural ...

A new study has uncovered a previously unknown plastome structural variation in the variegated plant Dianella tasmanica, ...

James Hamilton; Chief of Discovery and Translational Medicine; Arrowhead Pharmaceuticals Inc. Kenneth Myszkowski; Chief Financial Officer; Arrowhead Pharmaceuticals Inc. Unidentif ...

Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported a larger-than-expected loss for Q1 FY2025, with earnings per share (EPS) at -$1.39, missing the forecast of -$0.39. Revenue also fell short, totaling ...